Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Net Margin % : 12.86% (As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

What is Taro Pharmaceutical Industries Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Taro Pharmaceutical Industries's Net Income for the three months ended in Dec. 2023 was $20.2 Mil. Taro Pharmaceutical Industries's Revenue for the three months ended in Dec. 2023 was $157.1 Mil. Therefore, Taro Pharmaceutical Industries's net margin for the quarter that ended in Dec. 2023 was 12.86%.

The historical rank and industry rank for Taro Pharmaceutical Industries's Net Margin % or its related term are showing as below:

TARO' s Net Margin % Range Over the Past 10 Years
Min: -70.43 Med: 39.97 Max: 56.9
Current: 7.48

TARO's Net Margin % is ranked better than
63.43% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 3.5 vs TARO: 7.48

Taro Pharmaceutical Industries Net Margin % Historical Data

The historical data trend for Taro Pharmaceutical Industries's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taro Pharmaceutical Industries Net Margin % Chart

Taro Pharmaceutical Industries Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Net Margin %

Get a 7-Day Free Trial

42.06

37.88

-70.43

10.38

4.44

Taro Pharmaceutical Industries Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %	Get a 7-Day Free Trial															5.22	4.72	6.31	5.77	12.86

Competitive Comparison of Taro Pharmaceutical Industries's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Taro Pharmaceutical Industries's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's Net Margin % distribution charts can be found below:

* The bar in red indicates where Taro Pharmaceutical Industries's Net Margin % falls into.

Taro Pharmaceutical Industries Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Taro Pharmaceutical Industries's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin	=	Net Income (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	25.445	/	572.952
	=	4.44 %

Taro Pharmaceutical Industries's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	20.208	/	157.145
	=	12.86 %

Taro Pharmaceutical Industries (NYSE:TARO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Taro Pharmaceutical Industries Net Margin % Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (NYSE:TARO) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

TAL:Germany

Address

14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761

Website

https://www.taro.com

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.

Executives

Sun Pharma Global Inc	10 percent owner
Sun Pharmaceutical Industries Ltd	10 percent owner, other: Affiliated Party	17/B, MAHAL INDUSTRIAL ESTATE, MAHAKALI CAVES ROAD, ANDEHERI (EAST) K7 400 093
Alkaloida Chemical Co Exclusive Group Ltd.	10 percent owner	KABAY JANOS UT 29., TISZAVASVARI K5 4440
Franklin Resources Inc	10 percent owner	FRANKLIN RESOURCES INC, ONE FRANKLIN PARKWAY, SAN MATEO CA 94403